LILLY

THE MARK CONSISTS OF A CONFIGURATION OF A THREE DIMENSIONAL TABLET IN THE SHAPE OF AN IRREGULAR OBLONG; WITH THE WORD "LILLY" IN SCRIPT DEBOSSED ON THE FACE OF THE TABLET; IN THE COLORS LIGHT YELLOW, WITH DARK YELLOW ON THE SIDES OF THE TABLET AND FRAMING THE WORD "LILLY".

Mark For: LILLY™ trademark registration is intended to cover the categories of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases. [all]

>The color(s) THE COLOR(S) LIGHT YELLOW, DARK YELLOW IS/ARE CLAIMED AS A FEATURE OF THE MARK. is/are claimed as a feature of the mark. THE MARK CONSISTS OF A CONFIGURATION OF A THREE DIMENSIONAL TABLET IN THE SHAPE OF AN IRREGULAR OBLONG; WITH THE WORD "LILLY" IN SCRIPT DEBOSSED ON THE FACE OF THE TABLET; IN THE COLORS LIGHT YELLOW, WITH DARK YELLOW ON THE SIDES OF THE TABLET AND FRAMING THE WORD "LILLY".

Status

2021-07-25 UTC
⟳ Refresh

DEAD APPLICATION Refused Dismissed or Invalidated

Research	OneLook Acronym Finder
Serial Number	86612330
Mark Literal Elements	LILLY
Mark Drawing Type	3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED 2016-06-30
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Bruce W. Longbottom
Law Office Assigned	M10
Employee Name	DIXON, JENNIFER HAZARD

Timeline

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases